Dr. Leo Petrossian is a co-founder of the venture and will be stepping into the role of Chief Executive Officer. Dr. Petrossian, a repeat entrepreneur, will oversee the business aspects of the venture. After earning his doctorate in biomolecular nanotechnology, Dr. Petrossian, a MBA candidate at the UCLA Anderson, spent the following five years developing novel nanotechnologies within the biotech space.

Mr. Dan Hanchey is a co-founder of the venture and will be stepping into the role of Vice President of Business Development. Mr. Hanchey is a third-year MBA candidate at UCLA Anderson who has 16 years of software development experience. As a senior software architect, Mr. Hanchey led a team of 12 software developers responsible for a market leading CAD/CAM application.

Mr. Robert Hamilton is a co-founder of the venture and will be stepping into the role of Vice President of Research and Development. A fifth-year PhD candidate in Biomedical Engineering at UCLA, Mr. Hamilton has spent the past four years refining and developing this technology within an academic setting and has several publications and presentations on the topics of ICP, and both acute and chronic brain injuries.